Published in Genes Chromosomes Cancer on February 01, 1993
The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis. Br J Cancer (1994) 2.14
p53 inactivation by MDM2 and MDMX negative feedback loops in testicular germ cell tumors. Cell Cycle (2010) 1.06
Risk of cancer in relatives of testicular cancer patients. Br J Cancer (1996) 0.98
A male germ cell tumor-susceptibility-determining locus, pgct1, identified on murine chromosome 13. Proc Natl Acad Sci U S A (2000) 0.97
Molecular genetics of testicular germ cell tumors. Am J Cancer Res (2012) 0.89
Germ cell tumors of the testis overexpress wild-type p53. Am J Pathol (1996) 0.88
Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells. Curr Cancer Ther Rev (2006) 0.88
Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinoma. Mol Oncol (2011) 0.84
Prediction of P53 mutants (multiple sites) transcriptional activity based on structural (2D&3D) properties. PLoS One (2013) 0.79
Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med (2013) 13.90
Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat Med (1996) 7.32
Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med (1992) 2.64
Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res (1993) 2.48
High dose epirubicin is effective in measurable metastatic prostate cancer: a phase II study of the EORTC Genitourinary Group. Eur J Cancer (1995) 2.10
Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites. Genes Chromosomes Cancer (1998) 2.09
Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol (1996) 2.03
Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis (2013) 2.02
Components of the metabolic syndrome in long-term survivors of testicular cancer. Ann Oncol (2006) 1.85
Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene (2000) 1.83
Familial testicular cancer in Norway and southern Sweden. Br J Cancer (1996) 1.76
Somatic mutations in LKB1 are rare in sporadic colorectal and testicular tumors. Cancer Res (1998) 1.75
Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3. Urology (2003) 1.72
Coexistence of episomal and integrated HPV16 DNA in squamous cell carcinoma of the cervix. J Clin Pathol (1994) 1.70
Crystalluria and ciprofloxacin, influence of urinary pH and hydration. Chemotherapy (1986) 1.66
Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. Proc Natl Acad Sci U S A (1991) 1.65
Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer (2004) 1.64
Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III). Breast Cancer Res Treat (1999) 1.63
Molecular heterogeneity in the mild autosomal dominant forms of osteogenesis imperfecta. Am J Hum Genet (1984) 1.62
The level of physical activity in long-term survivors of testicular cancer. Eur J Cancer (2003) 1.61
Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J Clin Oncol (1995) 1.60
Expression of the neuroectodermal intermediate filament nestin in human melanomas. Cancer Res (1994) 1.58
Anxiety, depression, and quality of life in caregivers of patients with cancer in late palliative phase. Ann Oncol (2005) 1.58
Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int J Cancer (1997) 1.57
Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas. Hum Mol Genet (1995) 1.57
WNT1 inducible signaling pathway protein 3, WISP-3, a novel target gene in colorectal carcinomas with microsatellite instability. Gastroenterology (2001) 1.56
Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome. J Pathol (2001) 1.54
Molecular genetic changes in human male germ cell tumors. Lab Invest (1995) 1.53
Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer. J Clin Oncol (2000) 1.51
TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, CDK4, RB, MDM2, and EGFR in cancers of the uterine corpus. J Pathol (1999) 1.44
Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis. Int J Gynecol Pathol (1998) 1.44
Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.43
Deletion of 1p loci and microsatellite instability in colorectal polyps. Genes Chromosomes Cancer (1995) 1.43
[Prolonged neck pain following automobile accidents. Gender and age related risk calculated on basis of data from an emergency department]. Ugeskr Laeger (2000) 1.41
High-density lipoprotein as carrier for amyloid-related protein SAA in rabbit serum. Scand J Immunol (1979) 1.41
Marfan syndrome: exclusion of genetic linkage to the COL1A2 gene. Clin Genet (1986) 1.40
Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology. Pharmacogenetics (1995) 1.39
Carcinoma of the prostate with soft tissue or non-regional lymphatic metastases at the time of diagnosis: a review of 47 cases. Br J Urol (1984) 1.39
Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience. J Clin Oncol (1991) 1.39
Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series. Ann Oncol (2012) 1.37
[Changes in spongiosa fine structure under the influence of polymerizing bone cement (scanning electron microscopic studies)]. Z Orthop Ihre Grenzgeb (1970) 1.35
Expression of laminin, collagen IV, fibronectin, and type IV collagenase in gastric carcinoma. An immunohistochemical study of 87 patients. Cancer (1994) 1.31
A segregation analysis of testicular cancer based on Norwegian and Swedish families. Br J Cancer (1997) 1.31
Prognostic significance of TP53 alterations in breast carcinoma. Br J Cancer (1993) 1.30
Anxiety and depression in cancer patients: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire. J Psychosom Res (2000) 1.27
Parenthood probability and pregnancy outcome in patients with a cancer diagnosis during adolescence and young adulthood. Hum Reprod (2007) 1.27
Cancer patients' awareness about their diagnosis: a population-based study. J Public Health Med (2003) 1.25
Excessive annual BMI increase after chemotherapy among young survivors of testicular cancer. Br J Cancer (2003) 1.23
Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas. Genes Chromosomes Cancer (1992) 1.22
Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cancer Res (1994) 1.21
Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma. Clin Cancer Res (2000) 1.19
Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma. Int J Cancer (2001) 1.18
Comparison of two intervention programmes in young female players in European handball--with and without ankle disc. Scand J Med Sci Sports (2003) 1.18
Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum Genet (1994) 1.18
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. Ann Oncol (2006) 1.18
Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival. Am J Pathol (1998) 1.17
Late recurrences of germ cell malignancies: a population-based experience over three decades. Br J Cancer (2006) 1.17
Assessment of clonal relationships in ipsilateral and bilateral multiple breast carcinomas by comparative genomic hybridisation and hierarchical clustering analysis. Br J Cancer (2004) 1.17
Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas. J Pathol (1993) 1.16
Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol Biol Phys (1999) 1.15
Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein. Proc Natl Acad Sci U S A (1992) 1.15
p53 mutations in lung tumors: relationship to putative susceptibility markers for cancer. Cancer Res (1994) 1.15
Risk of a second germ cell cancer after treatment of a primary germ cell cancer in 2201 Norwegian male patients. Eur J Cancer (1997) 1.15
[Electron microscopic scanning in normal and arthrotic articular cartilage]. Z Orthop Ihre Grenzgeb (1970) 1.13
A common BRCA1 mutation in Norwegian breast and ovarian cancer families? Am J Hum Genet (1996) 1.12
Genetic alterations within the retinoblastoma locus in colorectal carcinomas. Relation to DNA ploidy pattern studied by flow cytometric analysis. Br J Cancer (1991) 1.12
Constant denaturant gel electrophoresis, a modification of denaturing gradient gel electrophoresis, in mutation detection. Mutat Res (1991) 1.12
Trends in incidence of testicular cancer in Norway 1955-1992. Eur J Cancer (1995) 1.12
Detection of c-erbB-2 related protein in sera from breast cancer patients. Relationship to ERBB2 gene amplification and c-erbB-2 protein overexpression in tumour. Acta Oncol (1995) 1.11
Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1). J Pathol (2006) 1.10
Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working Party. Eur J Cancer (1997) 1.09
Yet another machine fault. Anesthesiology (1983) 1.09
Blood pressure and body mass index in long-term survivors of testicular cancer. J Clin Oncol (2005) 1.09
Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence. Br J Cancer (2004) 1.08
Testicular neoplasms occurring in four brothers. A search for a genetic predisposition. Cancer (1985) 1.08
Prevalence of anxiety and depression in cancer patients seen at the Norwegian Radium Hospital. Eur J Cancer (1997) 1.08
Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri. J Pathol (1993) 1.08
Primary breast cancer. Flow cytometric DNA pattern in relation to clinical and histopathologic characteristics. Cancer (1986) 1.07
Assessments of clonal composition of colorectal adenomas by FISH analysis of chromosomes 1, 7, 13 and 20. Int J Cancer (2001) 1.07
The gene for apolipoprotein C-II is closely linked to the gene for apolipo-protein E on chromosome 19. Clin Genet (1984) 1.07
p53 abnormalities in different subtypes of human sarcomas. Cancer Res (1993) 1.07
DNA copy number changes in malignant ovarian germ cell tumors. Cancer Res (2000) 1.07
Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer. J Clin Oncol (1999) 1.07
Relationship between abnormal p53 protein and failure to express p21 protein in human breast carcinomas. J Pathol (1997) 1.06
SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis. Oncogene (2011) 1.06
Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study. Br J Cancer (2009) 1.06
Evaluation of loss of heterozygosity/allelic imbalance scoring in tumor DNA. Cancer Genet Cytogenet (2001) 1.05
Human CYP1A1 (cytochrome P(1)450) gene: lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics (1991) 1.05